Acceleration of crossbridge kinetics by protein kinase A phosphorylation of cardiac myosin binding protein C modulates cardiac function.
Normal cardiac function requires dynamic modulation of contraction. beta1-adrenergic-induced protein kinase (PK)A phosphorylation of cardiac myosin binding protein (cMyBP)-C may regulate crossbridge kinetics to modulate contraction. We tested this idea with mechanical measurements and echocardiography in a mouse model lacking 3 PKA sites on cMyBP-C, ie, cMyBP-C(t3SA). We developed the model by transgenic expression of mutant cMyBP-C with Ser-to-Ala mutations on the cMyBP-C knockout background. Western blots, immunofluorescence, and in vitro phosphorylation combined to show that non-PKA-phosphorylatable cMyBP-C expressed at 74% compared to normal wild-type (WT) and was correctly positioned in the sarcomeres. Similar expression of WT cMyBP-C at 72% served as control, ie, cMyBP-C(tWT). Skinned myocardium responded to stretch with an immediate increase in force, followed by a transient relaxation of force and finally a delayed development of force, ie, stretch activation. The rate constants of relaxation, k(rel) (s-1), and delayed force development, k(df) (s-1), in the stretch activation response are indicators of crossbridge cycling kinetics. cMyBP-C(t3SA) myocardium had baseline k(rel) and k(df) similar to WT myocardium, but, unlike WT, k(rel) and k(df) were not accelerated by PKA treatment. Reduced dobutamine augmentation of systolic function in cMyBP-C(t3SA) hearts during echocardiography corroborated the stretch activation findings. Furthermore, cMyBP-C(t3SA) hearts exhibited basal echocardiographic findings of systolic dysfunction, diastolic dysfunction, and hypertrophy. Conversely, cMyBP-C(tWT) hearts performed similar to WT. Thus, PKA phosphorylation of cMyBP-C accelerates crossbridge kinetics and loss of this regulation leads to cardiac dysfunction.
Tong
Carl W
CW
Department of Physiology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA.
Stelzer
Julian E
JE
Greaser
Marion L
ML
Powers
Patricia A
PA
Moss
Richard L
RL
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000818:Animals; D006332:Cardiomegaly / Q000000981:diagnostic imaging / Q000201:enzymology* / Q000503:physiopathology; D002352:Carrier Proteins / Q000235:genetics / Q000378:metabolism*; D017868:Cyclic AMP-Dependent Protein Kinases / Q000378:metabolism*; D004280:Dobutamine / Q000494:pharmacology; D015150:Echocardiography, Doppler; D006801:Humans; D007700:Kinetics; D040542:Mechanotransduction, Cellular; D051379:Mice; D008822:Mice, Transgenic; D053580:Muscle Strength; D009154:Mutation; D009200:Myocardial Contraction / Q000187:drug effects; D009206:Myocardium / Q000201:enzymology* / Q000473:pathology; D009210:Myofibrils / Q000201:enzymology; D010766:Phosphorylation; D012518:Sarcomeres / Q000201:enzymology; D019210:Troponin I / Q000378:metabolism; D000099163:Myosin Binding Protein C
D000318:Adrenergic beta-Agonists; D002352:Carrier Proteins; D017868:Cyclic AMP-Dependent Protein Kinases; D004280:Dobutamine; D019210:Troponin I; D000099163:Myosin Binding Protein C
J Clin Invest. 1999 Nov;104(9):1235-44
10545522
J Biol Chem. 1993 Feb 5;268(4):2705-11
8381412
J Mol Biol. 1999 Feb 26;286(3):933-49
10024460
FEBS Lett. 1999 Jun 25;453(3):254-9
10405155
Circulation. 2005 Feb 22;111(7):906-12
15699252
Mayo Clin Proc. 2005 Apr;80(4):463-9
15819282
Circ Res. 2005 Nov 25;97(11):1156-63
16224063
Cardiovasc Res. 2006 Feb 1;69(2):370-80
16380103
Biophys J. 2006 Jun 1;90(11):4119-27
16513777
Biophys J. 1994 Jul;67(1):273-82
7918995
Nature. 1995 Apr 6;374(6522):553-5
7700382
EMBO J. 1995 May 1;14(9):1952-60
7744002
Cardiovasc Drugs Ther. 1995 Feb;9(1):151-7
7786836
J Mol Cell Cardiol. 1995 Jul;27(7):1383-91
7473784
Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8999-9003
8799143
J Physiol. 1997 Jan 1;498 ( Pt 1):3-15
9023764
J Mol Biol. 1997 Feb 14;266(1):8-14
9054965
Biophys J. 1998 Mar;74(3):1439-51
9512040
J Clin Invest. 2006 Jun;116(6):1547-60
16741575
Transl Res. 2006 Jul;148(1):30-6
16887496
Circulation. 2006 Aug 15;114(7):670-80
16894034
Proteomics. 2006 Jul;6(14):4176-86
16791825
Circ Res. 2006 Oct 13;99(8):884-90
16973906
Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16918-23
17075052
Am J Physiol Heart Circ Physiol. 2007 Apr;292(4):H1747-54
17122190
Biochemistry. 2007 Jun 12;46(23):7054-61
17503784
J Mol Cell Cardiol. 2007 Aug;43(2):223-9
17560599
Circ Res. 2007 Aug 31;101(5):503-11
17641226
J Physiol. 2001 Jan 15;530(Pt 2):263-72
11208974
Circ Res. 2001 May 25;88(10):1059-65
11375276
Biochemistry. 2001 Nov 20;40(46):13915-24
11705381
Circ Res. 2001 Dec 7;89(12):1184-90
11739284
JAMA. 2002 Mar 13;287(10):1308-20
11886323
Circ Res. 2002 Mar 22;90(5):594-601
11909824
JAMA. 2003 Jan 8;289(2):194-202
12517230
Circulation. 2003 May 6;107(17):2227-32
12707239
Circ Res. 2004 May 14;94(9):1249-55
15059932
Circ Res. 2004 May 28;94(10):1290-300
15166116
J Physiol. 2004 Aug 1;558(Pt 3):927-41
15194741
J Mol Biol. 1967 Dec 14;30(2):383-434
5586931
J Mol Biol. 1973 Mar 15;74(4):653-76
4269687
Proc R Soc Lond B Biol Sci. 1976 Mar 16;192(1109):451-61
4802
J Biol Chem. 1984 Dec 25;259(24):15587-96
6549009
J Biol Chem. 1991 Feb 15;266(5):2811-7
1671569
Circ Res. 1998 Jul 13;83(1):60-72
9670919